{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:02:46Z","timestamp":1792501366423,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jns.2017.03.033","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T15:01:09Z","timestamp":1490626869000},"page":"19-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Juvenile dermatomyositis\/polymyositis and lymphoma"],"prefix":"10.1016","volume":"377","author":[{"given":"Joerg-Patrick","family":"St\u00fcbgen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2017.03.033_bb0005","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) \u2013 clinical characteristics of children recruited within the first 5 years","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jns.2017.03.033_bb0010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-857X(02)00024-8","article-title":"Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes","volume":"28","author":"Ramanan","year":"2002","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.jns.2017.03.033_bb0015","first-page":"1329","article-title":"Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963\u20131982","volume":"17","author":"Oddis","year":"1990","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jns.2017.03.033_bb0020","first-page":"2143","article-title":"Incidence of systemic connective diseases in children: a nationwide prospective study in Finland","volume":"21","author":"Pelkonen","year":"1994","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jns.2017.03.033_bb0025","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/rheumatology\/34.8.732","article-title":"The incidence of juvenile dermatomyositis: results from a nation-wide study","volume":"34","author":"Symmons","year":"1995","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jns.2017.03.033_bb0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","article-title":"US incidence of juvenile dermatomyositis, 1995-1998: results fro the National Institute of Arthritis and Musculoskeletal and Skin Diseases registry","volume":"49","author":"Mendez","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2017.03.033_bb0035","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Sch\u00f6nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2017.03.033_bb0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpeds.2005.10.032","article-title":"Duration of illness is an important variable for untreated children with juvenile dermatomyositis","volume":"148","author":"Pachman","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jns.2017.03.033_bb0045","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11926-005-0048-1","article-title":"Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going?","volume":"7","author":"Huber","year":"2005","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jns.2017.03.033_bb0050","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.38137","article-title":"Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders","volume":"65","author":"Miller","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2017.03.033_bb0055","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/art.37985","article-title":"Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis","volume":"65","author":"Shah","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2017.03.033_bb0060","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/acr.22358","article-title":"Risk factors for juvenile dermatomyositis: exposure to tobacco and air pollutants during pregnancy","volume":"66","author":"Orione","year":"2014","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jns.2017.03.033_bb0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.berh.2009.07.007","article-title":"Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment","volume":"23","author":"Wederburn","year":"2009","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jns.2017.03.033_bb0070","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/01.bor.0000434674.62644.02","article-title":"Update in juvenile myositis","volume":"25","author":"Nistala","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jns.2017.03.033_bb0075","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/BOR.0000000000000103","article-title":"Recent advances in juvenile idiopathic inflammatory myopathies","volume":"26","author":"Ernste","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jns.2017.03.033_bb0080","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/BOR.0b013e3283635634","article-title":"An update on inflammatory myositis in children","volume":"25","author":"Huber","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jns.2017.03.033_bb0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/joim.12444","article-title":"The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes","volume":"280","author":"Rider","year":"2016","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jns.2017.03.033_bb0090","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other inflammatory myopathies of childhood","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2017.03.033_bb0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MPH.0b013e3181bf29a2","article-title":"Juvenile dermatomyositis as a paraneoplastic phenomenon: an update","volume":"32","author":"Morris","year":"2010","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.jns.2017.03.033_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jns.2016.08.060","article-title":"Inflammatory myopathies and lymphoma","volume":"369","author":"St\u00fcbgen","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2017.03.033_bb0105","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(00)03535-2","article-title":"Relation between dermatomyositis and polymyositis and cancer","volume":"357","author":"Callen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2017.03.033_bb0110","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1365-2133.2001.04140.x","article-title":"Predicting factors of malignancy in dermatomyositis and polymyositis: a case control study","volume":"144","author":"Chen","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jns.2017.03.033_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11926-002-0087-9","article-title":"Malignancy in patients with inflammatory myopathy","volume":"4","author":"Buchbinder","year":"2002","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jns.2017.03.033_bb0120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","article-title":"Risk of cancer in patients with dermatomyositis and polymyositis. A population-based study","volume":"326","author":"Sigurgeisson","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2017.03.033_bb0125","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2133.2009.09274.x","article-title":"Malignancies associated with dermatomyostis and polymyositis in Taiwan: a nationwide population-based study","volume":"161","author":"Huang","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jns.2017.03.033_bb0130","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/rheumatology\/kep302","article-title":"Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset","volume":"48","author":"Sanner","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jns.2017.03.033_bb0135","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","article-title":"Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients","volume":"62","author":"Ravelli","year":"2010","journal-title":"Arthritis Care Res."},{"issue":"2","key":"10.1016\/j.jns.2017.03.033_bb0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/ar4198","article-title":"Adult and juvenile dermatomyositis: are the distinct clinical feature explained by our current understanding of serological subgroups and pathogenic mechanisms?","volume":"15","author":"Tansley","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jns.2017.03.033_bb0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1182\/blood.V21.2.197.197","article-title":"Occurrence of leukemia and lymphoma in patients with agammaglobulinemia","volume":"21","author":"Page","year":"1963","journal-title":"Blood"},{"key":"10.1016\/j.jns.2017.03.033_bb0150","first-page":"83","article-title":"Secondary dermatomyositis in a child with reticulosarcomatosis","volume":"21","author":"Zhvaniia","year":"1976","journal-title":"Vopr. Okhr. Materin Det."},{"key":"10.1016\/j.jns.2017.03.033_bb0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/1097-0142(197907)44:1<112::AID-CNCR2820440120>3.0.CO;2-7","article-title":"Autoimmune disorders complicating adolescent Hodgkin's disease","volume":"44","author":"Kedar","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2017.03.033_bb0160","first-page":"141","article-title":"Lymphogranulomatosis and dermatomyositis","volume":"22","author":"D\u00f6ring","year":"1983","journal-title":"Padiatr. Grenzgeb."},{"key":"10.1016\/j.jns.2017.03.033_bb0165","first-page":"528","article-title":"Primary lymphoma of the skin in a 10-year-old child with dermatomyositis","volume":"39","author":"Lehotsk\u00e1","year":"1984","journal-title":"Cesk Pediatr."},{"key":"10.1016\/j.jns.2017.03.033_bb0170","first-page":"1708","article-title":"A case of dermatomyositis associated with cutaneous T cell lymphoma","volume":"26","author":"Kawano","year":"1985","journal-title":"Jpn. J. Clin. Hematol."},{"key":"10.1016\/j.jns.2017.03.033_bb0175","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/BF01707284","article-title":"Dermatomyositis as presenting symptom of Hodgkin's disease","volume":"63","author":"Shay","year":"1991","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.jns.2017.03.033_bb0180","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0887-8994(93)90055-H","article-title":"Childhood polymyositis as a paraneoplastic phenomenon","volume":"9","author":"Sherry","year":"1993","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jns.2017.03.033_bb0185","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/ard.54.7.607-b","article-title":"Early development of Hodgkin's lymphoma in association with the use of methotrexate for the treatment of dermatomyositis","volume":"54","author":"Bittar","year":"1995","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2017.03.033_bb0190","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0248-8663(01)00456-8","article-title":"Juvenile dermatomyositis and panniculitis-type subcutaneous T-cell lymphoma. A case report","volume":"22","author":"Laraki","year":"2001","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.jns.2017.03.033_bb0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1525-1470.2009.00875.x","article-title":"Lymphoma arising from calcinotic lesion in a patient with juvenile dermatomyositis","volume":"26","author":"Morris","year":"2009","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.jns.2017.03.033_bb0200","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0046-8177(94)90295-X","article-title":"Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression","volume":"25","author":"Kamel","year":"1994","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jns.2017.03.033_bb0205","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1182\/blood-2003-08-2986","article-title":"Epstein-Barr virus infection in Western European pediatric non-Hodgkin lymphomas","volume":"102","author":"Karajannis","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jns.2017.03.033_bb0210","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1023\/A:1025698109991","article-title":"No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands)","volume":"14","author":"Beidenbeck","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jns.2017.03.033_bb0215","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/ard.2005.036459","article-title":"Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica\/giant cell arteritis","volume":"64","author":"Askling","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2017.03.033_bb0220","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/rheumatology\/kel396","article-title":"Non-Hodgkin's lymphoma-meta-analyses of the effects of corticosteroids and non-steroidal anti-inflammatories","volume":"46","author":"Bernatsky","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jns.2017.03.033_bb0225","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.revmed.2013.10.336","article-title":"Autoimmune diseases and cancers. Part I: cancers complicating autoimmune diseases and their treatment","volume":"35","author":"Pasquet","year":"2014","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.jns.2017.03.033_bb0230","first-page":"1","article-title":"Autoimmunity and B-cell malignancies","volume":"40","author":"Dighiero","year":"1998","journal-title":"Hematol. Cell Ther."},{"key":"10.1016\/j.jns.2017.03.033_bb0235","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.revmed.2004.11.011","article-title":"Auto-immune manifestations in non-Hodgkin's lymphoma","volume":"26","author":"Jardin","year":"2005","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.jns.2017.03.033_bb0240","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ncprheum0620","article-title":"B-cell lymphoproliferation in chronic inflammatory rheumatic diseases","volume":"3","author":"Hansen","year":"2007","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.jns.2017.03.033_bb0245","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jns.2017.03.033_bb0250","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1586\/1744666X.4.2.247","article-title":"Development of autoimmunity in lymphoma","volume":"4","author":"Jardin","year":"2008","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.jns.2017.03.033_bb0255","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2796.2008.02029.x","article-title":"Autoimmune and inflammatory disorders and risk of malignant lymphomas-an update","volume":"264","author":"Smedby","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jns.2017.03.033_bb0260","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1136\/annrheumdis-2015-207659","article-title":"Autoimmune diseases in adult life after childhood cancer in Scandinavia (ALiSS)","volume":"75","author":"Holmqvist","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2017.03.033_bb0265","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semcancer.2013.12.001","article-title":"Lymphoma development in patients with autoimmune and inflammatory disorders-what are the driving forces?","volume":"24","author":"Baecklund","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jns.2017.03.033_bb0270","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2017.03.033_bb0275","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sj\u00f6gren's syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jns.2017.03.033_bb0280","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, celiac disease, and enteropathy-associated T-cell lymphoma: French Celiac Disease Study Group","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2017.03.033_bb0285","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.4049\/jimmunol.179.7.4929","article-title":"Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sj\u00f6gren's syndrome","volume":"179","author":"Bombardieri","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2017.03.033_bb0290","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1002\/art.11286","article-title":"Extrasalivary lymphoma development in Sj\u00f6gren's syndrome: clonal evolution from parotid gland lymphoproliferation and role of local triggering","volume":"48","author":"Gasparotto","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2017.03.033_bb0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(05)70434-4","article-title":"Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium","volume":"7","author":"Rothman","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jns.2017.03.033_bb0300","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(07)60279-7","article-title":"Systemic lupus erythematosus","volume":"369","author":"D'Cruz","year":"2007","journal-title":"Lancet"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17302022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17302022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T12:06:40Z","timestamp":1601813200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X17302022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":60,"alternative-id":["S0022510X17302022"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.03.033","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juvenile dermatomyositis\/polymyositis and lymphoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}